De esta forma, los casinos con bono de bienvenida consiguen más jugadores, y a la vez estos reciben más oportunidades de jugar y ganar. El mejor casino online con bono de bienvenida es aquel que ofrece bajo rollover y mayor margen de tiempo para utilizar el bono. Requisitos como el rollover, que indica la cantidad de veces que debes apostar el valor del bono, suelen ser difíciles de cumplir. Tal como su nombre indica, los casinos con bono de bienvenida sin depósito brindan saldo extra sin la necesidad de que ingreses fondos. Los casinos con bono de bienvenida por depósito otorgan un saldo extra calculado como un porcentaje sobre tu depósito inicial. Los bonos de bienvenida son un beneficio que el casino otorga a los jugadores que se registran por primera vez en la plataforma.

Apenas te registres con tu correo, métete a la configuración interna y bloquea de inmediato tu límite de depósito en un monto cómodo. Debes comprender firmemente que los bonos de casino online nunca deben considerarse como una solución a problemas económicos ni una fuente fija de ingresos para pagar tus cuentas. Lo prudente es buscar en el catálogo juegos clasificados de baja volatilidad que tiran premios chiquititos pero constantes para ir liberando tus bonos de casino con seguridad. Una máquina de alta volatilidad tiene la capacidad de darte un premio gigante, pero también te puede dar 50 giros seguidos en blanco total sin devolverte ni un solo peso para sostener tus bonos de casino. Todo el mercado de promociones y recompensas de casino está pensado, programado y diseñado primero para pantallas chicas. Todo el mundo en Chile exige poder jugar y usar sus bonos de casino desde la comodidad de su celular mientras viaja en la micro o espera en el metro. Mucha gente cree que esto es una estafa para no pagar la plata ganada con las bonificaciones de casino.

Granawin sobresale entre los casinos con bono de bienvenida al combinar una oferta estándar, código CLWIN, primer y segundo depósito, además de un juego de bono adicional. Algunos combinan un bono de casino estándar con códigos promocionales, beneficios para el primer y segundo depósito de casino online, giros gratis o promociones adicionales. No todos los casinos con bono de bienvenida tienen la misma estructura promocional. Muchos problemas con los retiros se deben a que aún falta completar el rollover. 💡 Ojo con estoEn la mayoría de casinos chilenos solo se permite una promoción activa a la vez. Antes de depositar, confirma el monto mínimo, el rollover y si el bono necesita código.

Podemos jugarlos en todos los juegos pero las apuestas sólo contabilizarán con un 100% para la liberación en los juegos de tragamonedas. Actualmente, los mejores bonos para nuevos jugadores los están ofreciendo Cyber Bet y Surf Casino, por la facilidad que ofrecen las condiciones de liberación. Reclamar ofertas de bienvenida te permite aumentar al máximo tus posibilidades de ganar. Es una promoción exclusiva para jugadores que aún no tienen cuenta y se unen por primera vez. Es un regalo que los casinos online dan a los nuevos usuarios que se registran en su plataforma. Neon54 es un casino online de primer nivel que ofrece a los jugadores un emocionante bono de bienvenida. CasiGo es un casino online que sabe cómo cautivar a los nuevos jugadores chilenos con su emocionante bono de bienvenida.

Los juegos que puedes jugar con un bono son las tragamonedas online y los juegos de mesa. No puedes retirar tus ganancias seguramente por razones como incumplimiento del rollover u otro de los términos y condiciones estipulados por el casino. El mejor bono de casino es el de QuickWin, que se encuentra entre las mejores promociones de casino. Por ejemplo, las tragamonedas pueden contribuir con el 100%, mientras que los juegos de mesa, pueden contribuir con un pequeño porcentaje o ninguno. ¿Te imaginas lo decepcionante que sería activar un bono y después descubrir que no lo puedes usar para el juego que planeabas? Por ejemplo, un bono accesible es el ofrecido por TonyBet, el cual tiene un rollover de 35x y una vigencia de 30 días. Fíjate que el rollover no sea demasiado alto y que la vigencia no sea muy corta.

Además, el acceso a las ganancias depende del rollover, los juegos válidos, la verificación KYC y las condiciones de retiro de cada bono por registro de casino. Sin embargo, algunos casinos con bono de bienvenida sin depósito utilizan un formato distinto, con límites de uso y condiciones específicas. Antes de elegir tu casino en línea con bono de bienvenida, compara casinos con bonos. TonyBet forma parte de los casinos con bono de bienvenida más atractivos por su código TONYWELCL y sus recompensas escalonadas. National Casino destaca entre los casinos con bono de bienvenida por combinar primer depósito, segundo ingreso y Friday Reload. Ivibet se posiciona entre los casinos con bono de bienvenida más atractivos para nuevos jugadores gracias a su estructura escalonada.

Por esta razón es vital que siempre uses tus datos personales reales y farkas casino chile no intentes enmascarar tu conexión para obtener mejores bonos de casino de otros países. Vas a estar jugando meses enteros antes de liberar la plata de tus bonos de casino si decides jugar solo ruleta. Por esta razón técnica la inmensa mayoría de los usuarios se enfocan exclusivamente en estas máquinas cuando tienen los mejores bonos de casino activos. Hay operadores que aplican este requisito solo al monto específico que te regalaron en los bonos de casino. Estas plataformas te permiten reclamar paquetes de monedas gratuitas al registrarte o al iniciar sesión diariamente. Este modelo opera con monedas virtuales que no tienen valor comercial fuera de la página, pero igual entregan beneficios equivalentes a los bonos de casino tradicionales. Lo mejor de los reembolsos es que usualmente te entregan esa plata sin ataduras complejas, a diferencia de los bonos de casino tradicionales.

Retirar dinero en una casa de apuestas con bono de bienvenida es más fácil de lo que se dice. Encontrar un bono de bienvenida sin depósito en Chile es difícil, pero actualmente puedes encontrarlos en Vulkan Vegas, y Energy Casino. Tras el registro en el sitio de casinos, tendrás tus bonos de bienvenida gratis sin depósito para chile inmediatamente. Estos son los preferidos de todos los jugadores, ya sean de tiradas gratis o de un monto de bonificación. ¿Ya has probado los casinos online de Chile con bonos de bienvenida sin depósito? Generalmente, todos los bonos de bienvenida son por depósito y suelen incluir un porcentaje de ese depósito en forma de bono y algunos giros gratis extra para slots.

De esta forma, los casinos con bono de bienvenida consiguen más jugadores, y a la vez estos reciben más oportunidades de jugar y ganar. El mejor casino online con bono de bienvenida es aquel que ofrece bajo rollover y mayor margen de tiempo para utilizar el bono. Requisitos como el rollover, que indica la cantidad de veces que debes apostar el valor del bono, suelen ser difíciles de cumplir. Tal como su nombre indica, los casinos con bono de bienvenida sin depósito brindan saldo extra sin la necesidad de que ingreses fondos. Los casinos con bono de bienvenida por depósito otorgan un saldo extra calculado como un porcentaje sobre tu depósito inicial. Los bonos de bienvenida son un beneficio que el casino otorga a los jugadores que se registran por primera vez en la plataforma.

Apenas te registres con tu correo, métete a la configuración interna y bloquea de inmediato tu límite de depósito en un monto cómodo. Debes comprender firmemente que los bonos de casino online nunca deben considerarse como una solución a problemas económicos ni una fuente fija de ingresos para pagar tus cuentas. Lo prudente es buscar en el catálogo juegos clasificados de baja volatilidad que tiran premios chiquititos pero constantes para ir liberando tus bonos de casino con seguridad. Una máquina de alta volatilidad tiene la capacidad de darte un premio gigante, pero también te puede dar 50 giros seguidos en blanco total sin devolverte ni un solo peso para sostener tus bonos de casino. Todo el mercado de promociones y recompensas de casino está pensado, programado y diseñado primero para pantallas chicas. Todo el mundo en Chile exige poder jugar y usar sus bonos de casino desde la comodidad de su celular mientras viaja en la micro o espera en el metro. Mucha gente cree que esto es una estafa para no pagar la plata ganada con las bonificaciones de casino.

Granawin sobresale entre los casinos con bono de bienvenida al combinar una oferta estándar, código CLWIN, primer y segundo depósito, además de un juego de bono adicional. Algunos combinan un bono de casino estándar con códigos promocionales, beneficios para el primer y segundo depósito de casino online, giros gratis o promociones adicionales. No todos los casinos con bono de bienvenida tienen la misma estructura promocional. Muchos problemas con los retiros se deben a que aún falta completar el rollover. 💡 Ojo con estoEn la mayoría de casinos chilenos solo se permite una promoción activa a la vez. Antes de depositar, confirma el monto mínimo, el rollover y si el bono necesita código.

Podemos jugarlos en todos los juegos pero las apuestas sólo contabilizarán con un 100% para la liberación en los juegos de tragamonedas. Actualmente, los mejores bonos para nuevos jugadores los están ofreciendo Cyber Bet y Surf Casino, por la facilidad que ofrecen las condiciones de liberación. Reclamar ofertas de bienvenida te permite aumentar al máximo tus posibilidades de ganar. Es una promoción exclusiva para jugadores que aún no tienen cuenta y se unen por primera vez. Es un regalo que los casinos online dan a los nuevos usuarios que se registran en su plataforma. Neon54 es un casino online de primer nivel que ofrece a los jugadores un emocionante bono de bienvenida. CasiGo es un casino online que sabe cómo cautivar a los nuevos jugadores chilenos con su emocionante bono de bienvenida.

Los juegos que puedes jugar con un bono son las tragamonedas online y los juegos de mesa. No puedes retirar tus ganancias seguramente por razones como incumplimiento del rollover u otro de los términos y condiciones estipulados por el casino. El mejor bono de casino es el de QuickWin, que se encuentra entre las mejores promociones de casino. Por ejemplo, las tragamonedas pueden contribuir con el 100%, mientras que los juegos de mesa, pueden contribuir con un pequeño porcentaje o ninguno. ¿Te imaginas lo decepcionante que sería activar un bono y después descubrir que no lo puedes usar para el juego que planeabas? Por ejemplo, un bono accesible es el ofrecido por TonyBet, el cual tiene un rollover de 35x y una vigencia de 30 días. Fíjate que el rollover no sea demasiado alto y que la vigencia no sea muy corta.

Además, el acceso a las ganancias depende del rollover, los juegos válidos, la verificación KYC y las condiciones de retiro de cada bono por registro de casino. Sin embargo, algunos casinos con bono de bienvenida sin depósito utilizan un formato distinto, con límites de uso y condiciones específicas. Antes de elegir tu casino en línea con bono de bienvenida, compara casinos con bonos. TonyBet forma parte de los casinos con bono de bienvenida más atractivos por su código TONYWELCL y sus recompensas escalonadas. National Casino destaca entre los casinos con bono de bienvenida por combinar primer depósito, segundo ingreso y Friday Reload. Ivibet se posiciona entre los casinos con bono de bienvenida más atractivos para nuevos jugadores gracias a su estructura escalonada.

Por esta razón es vital que siempre uses tus datos personales reales y farkas casino chile no intentes enmascarar tu conexión para obtener mejores bonos de casino de otros países. Vas a estar jugando meses enteros antes de liberar la plata de tus bonos de casino si decides jugar solo ruleta. Por esta razón técnica la inmensa mayoría de los usuarios se enfocan exclusivamente en estas máquinas cuando tienen los mejores bonos de casino activos. Hay operadores que aplican este requisito solo al monto específico que te regalaron en los bonos de casino. Estas plataformas te permiten reclamar paquetes de monedas gratuitas al registrarte o al iniciar sesión diariamente. Este modelo opera con monedas virtuales que no tienen valor comercial fuera de la página, pero igual entregan beneficios equivalentes a los bonos de casino tradicionales. Lo mejor de los reembolsos es que usualmente te entregan esa plata sin ataduras complejas, a diferencia de los bonos de casino tradicionales.

Retirar dinero en una casa de apuestas con bono de bienvenida es más fácil de lo que se dice. Encontrar un bono de bienvenida sin depósito en Chile es difícil, pero actualmente puedes encontrarlos en Vulkan Vegas, y Energy Casino. Tras el registro en el sitio de casinos, tendrás tus bonos de bienvenida gratis sin depósito para chile inmediatamente. Estos son los preferidos de todos los jugadores, ya sean de tiradas gratis o de un monto de bonificación. ¿Ya has probado los casinos online de Chile con bonos de bienvenida sin depósito? Generalmente, todos los bonos de bienvenida son por depósito y suelen incluir un porcentaje de ese depósito en forma de bono y algunos giros gratis extra para slots.

De esta forma, los casinos con bono de bienvenida consiguen más jugadores, y a la vez estos reciben más oportunidades de jugar y ganar. El mejor casino online con bono de bienvenida es aquel que ofrece bajo rollover y mayor margen de tiempo para utilizar el bono. Requisitos como el rollover, que indica la cantidad de veces que debes apostar el valor del bono, suelen ser difíciles de cumplir. Tal como su nombre indica, los casinos con bono de bienvenida sin depósito brindan saldo extra sin la necesidad de que ingreses fondos. Los casinos con bono de bienvenida por depósito otorgan un saldo extra calculado como un porcentaje sobre tu depósito inicial. Los bonos de bienvenida son un beneficio que el casino otorga a los jugadores que se registran por primera vez en la plataforma.

Apenas te registres con tu correo, métete a la configuración interna y bloquea de inmediato tu límite de depósito en un monto cómodo. Debes comprender firmemente que los bonos de casino online nunca deben considerarse como una solución a problemas económicos ni una fuente fija de ingresos para pagar tus cuentas. Lo prudente es buscar en el catálogo juegos clasificados de baja volatilidad que tiran premios chiquititos pero constantes para ir liberando tus bonos de casino con seguridad. Una máquina de alta volatilidad tiene la capacidad de darte un premio gigante, pero también te puede dar 50 giros seguidos en blanco total sin devolverte ni un solo peso para sostener tus bonos de casino. Todo el mercado de promociones y recompensas de casino está pensado, programado y diseñado primero para pantallas chicas. Todo el mundo en Chile exige poder jugar y usar sus bonos de casino desde la comodidad de su celular mientras viaja en la micro o espera en el metro. Mucha gente cree que esto es una estafa para no pagar la plata ganada con las bonificaciones de casino.

Granawin sobresale entre los casinos con bono de bienvenida al combinar una oferta estándar, código CLWIN, primer y segundo depósito, además de un juego de bono adicional. Algunos combinan un bono de casino estándar con códigos promocionales, beneficios para el primer y segundo depósito de casino online, giros gratis o promociones adicionales. No todos los casinos con bono de bienvenida tienen la misma estructura promocional. Muchos problemas con los retiros se deben a que aún falta completar el rollover. 💡 Ojo con estoEn la mayoría de casinos chilenos solo se permite una promoción activa a la vez. Antes de depositar, confirma el monto mínimo, el rollover y si el bono necesita código.

Podemos jugarlos en todos los juegos pero las apuestas sólo contabilizarán con un 100% para la liberación en los juegos de tragamonedas. Actualmente, los mejores bonos para nuevos jugadores los están ofreciendo Cyber Bet y Surf Casino, por la facilidad que ofrecen las condiciones de liberación. Reclamar ofertas de bienvenida te permite aumentar al máximo tus posibilidades de ganar. Es una promoción exclusiva para jugadores que aún no tienen cuenta y se unen por primera vez. Es un regalo que los casinos online dan a los nuevos usuarios que se registran en su plataforma. Neon54 es un casino online de primer nivel que ofrece a los jugadores un emocionante bono de bienvenida. CasiGo es un casino online que sabe cómo cautivar a los nuevos jugadores chilenos con su emocionante bono de bienvenida.

Los juegos que puedes jugar con un bono son las tragamonedas online y los juegos de mesa. No puedes retirar tus ganancias seguramente por razones como incumplimiento del rollover u otro de los términos y condiciones estipulados por el casino. El mejor bono de casino es el de QuickWin, que se encuentra entre las mejores promociones de casino. Por ejemplo, las tragamonedas pueden contribuir con el 100%, mientras que los juegos de mesa, pueden contribuir con un pequeño porcentaje o ninguno. ¿Te imaginas lo decepcionante que sería activar un bono y después descubrir que no lo puedes usar para el juego que planeabas? Por ejemplo, un bono accesible es el ofrecido por TonyBet, el cual tiene un rollover de 35x y una vigencia de 30 días. Fíjate que el rollover no sea demasiado alto y que la vigencia no sea muy corta.

Además, el acceso a las ganancias depende del rollover, los juegos válidos, la verificación KYC y las condiciones de retiro de cada bono por registro de casino. Sin embargo, algunos casinos con bono de bienvenida sin depósito utilizan un formato distinto, con límites de uso y condiciones específicas. Antes de elegir tu casino en línea con bono de bienvenida, compara casinos con bonos. TonyBet forma parte de los casinos con bono de bienvenida más atractivos por su código TONYWELCL y sus recompensas escalonadas. National Casino destaca entre los casinos con bono de bienvenida por combinar primer depósito, segundo ingreso y Friday Reload. Ivibet se posiciona entre los casinos con bono de bienvenida más atractivos para nuevos jugadores gracias a su estructura escalonada.

Por esta razón es vital que siempre uses tus datos personales reales y farkas casino chile no intentes enmascarar tu conexión para obtener mejores bonos de casino de otros países. Vas a estar jugando meses enteros antes de liberar la plata de tus bonos de casino si decides jugar solo ruleta. Por esta razón técnica la inmensa mayoría de los usuarios se enfocan exclusivamente en estas máquinas cuando tienen los mejores bonos de casino activos. Hay operadores que aplican este requisito solo al monto específico que te regalaron en los bonos de casino. Estas plataformas te permiten reclamar paquetes de monedas gratuitas al registrarte o al iniciar sesión diariamente. Este modelo opera con monedas virtuales que no tienen valor comercial fuera de la página, pero igual entregan beneficios equivalentes a los bonos de casino tradicionales. Lo mejor de los reembolsos es que usualmente te entregan esa plata sin ataduras complejas, a diferencia de los bonos de casino tradicionales.

Retirar dinero en una casa de apuestas con bono de bienvenida es más fácil de lo que se dice. Encontrar un bono de bienvenida sin depósito en Chile es difícil, pero actualmente puedes encontrarlos en Vulkan Vegas, y Energy Casino. Tras el registro en el sitio de casinos, tendrás tus bonos de bienvenida gratis sin depósito para chile inmediatamente. Estos son los preferidos de todos los jugadores, ya sean de tiradas gratis o de un monto de bonificación. ¿Ya has probado los casinos online de Chile con bonos de bienvenida sin depósito? Generalmente, todos los bonos de bienvenida son por depósito y suelen incluir un porcentaje de ese depósito en forma de bono y algunos giros gratis extra para slots.

In October 2022, the company agreed to buy British diagnostics firm, The Binding Site Group, in an all-cash deal for US$2.6 billion from Nordic Capital. In April 2021, Thermo Fisher Scientific announced the acquisition of PPD, Inc., a contract research organization, for a total cash purchase price of $17.4 billion-plus the assumption of approximately $3.5 billion of net debt. On August 13, the company announced that its offer to acquire all of the ordinary share had lapsed, and it terminated the acquisition agreement. In August, the company acquired Patheon, a contract development and manufacturing organization serving the pharmaceutical and biotechnology sectors, for approximately $7.2 billion. In March, the company announced it would acquire Core Informatics, provider of cloud-based platforms supporting scientific data management. On May 27, 2016, the company announced it would acquire FEI Company for $4.2 billion, a manufacturer of electron microscopes. In February 2015, the company announced it would acquire Advanced Scientifics for $300 million in a cash-deal. In May 2011, Thermo Fisher Scientific Inc. bought Phadia to expand into the testing of allergies and autoimmune diseases for €2.47 billion ($3.5 billion) in cash.

It made broad patents covering Enhanced GFP (EGFP), GFP-based biosensors and any genetically encoded protein fusion to a luminophore, with subsequent monitoring of the protein's translocation within a cell as the primary readout for drug discovery assays. In 1990, Thermo Fisher Scientific (then known as Thermo Instrument Systems) acquired mass spectrometer manufacturer Finnigan Instrument Corporation. In April 2007, Genevac was sold to Riverlake Partners LLC and the merger closed with FTC approval. However, the Federal Trade Commission ruled that this acquisition was anti-competitive regarding centrifugal evaporators, requiring Fisher to divest Genevac. It ranked 106th on the Fortune 500 list based on its 2025 annual revenue of $44.556 billion. Thermo Fisher Scientific has acquired other reagent, consumable, instrumentation, Adrians Casino and service providers, including Life Technologies Corporation (2013), Alfa Aesar (2015), Affymetrix (2016), FEI Company (2016), BD Advanced Bioprocessing (2018), and PPD (2021). Based in Waltham, Massachusetts, Thermo Fisher was formed through the merger of Thermo Electron and Fisher Scientific in 2006. The merger closed on November 9, 2006, and the merged company is now called Thermo Fisher Scientific.

This acquisition is anticipated to close in early 2017 and will contribute to the growth of Thermo's Analytical Instruments business group. In January 2016, the company announced it would acquire Affymetrix for $1.3 billion. The company also acquired GIBCO (Grand Island Biological Company) as part of the Life Technologies acquisition. Life Technologies was originally formed in 2008 through a $6.7B merger of Invitrogen, a cell therapy, and Applied Biosystems. In April 2013, after a competitive bidding with Hoffmann-La Roche, Thermo Fisher acquired Life Technologies Corporation for US$13.6 billion in a deal, adding further service lines related to advanced DNA sequencing and genetic testing. In December 2010, Thermo Fisher Scientific announced its acquisition of Dionex for $2.1 billion.

In March 2019, Thermo Fisher Scientific announced its entry into the gene therapy manufacturing market with a $1.7 billion cash acquisition for Brammer Bio. Thermo Scientific products address a range of needs from sample, material characterization, and chemical analysis to clinical diagnoses and biological-based therapeutics manufacturing. As the world’s leader in serving science, our professionals develop critical solutions—and build rewarding careers. Discover the resources that match your professional development interests, a culture that welcomes your ideas, and opportunities that only a global leader can provide. Over 50 million tons of her cells have been produced and used in over 60,000 scientific studies touching virtually every realm of medicine, including the development of polio vaccines, gene mapping, in-vitro fertilization, and multitudes more. In 2021, Thermo Fisher announced the construction of a cell therapy development, manufacturing and collaboration center in cooperation with University of California, San Francisco on the school's Mission Bay campus.

Grab Deals Before They're Gone

In June 2020, Thermo Fisher Scientific was reported to sell its equipment to security services in China for use in what was alleged as part of a genetic surveillance program. In February 2019, Thermo Fisher Scientific announced that it would stop selling its equipment in Xinjiang. In May 2023, Thermo Fisher partnered with Pfizer, with plans to work together on expanding testing capabilities for lung and breast cancer patients. The collaboration was designed to scale up the manufacturing of Moderna’s COVID-19 vaccine and other investigational mRNA products. Previously, he worked for clinical diagnostics provider Dade Behring Inc., serving as President–Americas. After the merger creating Thermo Fisher Scientific in 2006, he was named Executive Vice President and President of its Analytical Technologies business, and in 2008 he became the company’s Chief Operating Officer. In July 2025, Thermo Fisher added drug manufacturing capabilities in the United States through its purchase of a sterile fill-finish and packaging plant from Sanofi in Ridgefield, New Jersey.

In February 2025, Thermo Fisher announced the acquisition of Solventum’s purification and filtration business for $4.1 billion. In July 2023, the business announced it would acquire CorEvitas, LLC from Audax Private Equity for more than $900 million in cash. In January 2022, Thermo Fisher Scientific acquired PeproTech, a developer and manufacturer of recombinant proteins, for $1.85 billion. In November, the business announced it would acquire PharmaFluidics and its μPAC range of micro-chip-based chromatography products. In March 2020, Thermo Fisher Scientific agreed to purchase Qiagen, a molecular diagnostics company, for $10.1 billion. In November the company announced it would acquire MTI-GlobalStem, a previously privately held company that develops reagents for cell transfection, neurobiology and stem cell research.

Green Solutions

In the 1990s, Fisher, with partner Intertech Corporation of Atkinson, New Hampshire, set up a pharmaceutical testing and certification lab in Moscow, Russia, to serve with the Russian Federation's Ministry of Health and Medical Industry needs. The public entity was called Fisher Scientific International Inc., and based in Hampton, New Hampshire. Fisher was acquired by Morristown, New Jersey–based Allied Corporation in 1981 for $330 million. In 1968, it purchased Massachusetts-based Jarrell-Ash Company, a producer of optical instrumentation, particularly for emission and atomic absorption spectroscopy. It acquired Pfeiffer Glass, Inc. in 1966, a manufacturer of high accuracy volumetric pipettes. In 1959 the company opened an instrument and supplies facility in Indiana, Pennsylvania. In 1957, the company purchased the New York–based medical apparatus supply company E. In 1955, Fisher established a chemical manufacturing facility in Fair Lawn, New Jersey.

The merger was complete in November 2006, and technology transfer to a US site was completed during 2007 and 2008. It focused on providing laboratory equipment, chemicals, supplies and services used in healthcare, scientific research, safety, and education. It acquired Chicago-based Stansi Scientific Company in 1967, expanding into educational science supplies. As part of our global team, what you do contribues directly to our Mission, to enable our customers to make the world healthier, cleaner and safer. The images were claimed to validate the effectiveness of antibody products which have uses including Western blots. In 2013, Opengate Capital Group LLC filed suit against Thermo Fisher Scientific for selling it a manufacturing plant controlled by the Gulf Cartel. In June 2021, The New York Times reported that, despite bans, Thermo Fisher Scientific equipment continued to be sold to police in Xinjiang.

In October 2022, the company agreed to buy British diagnostics firm, The Binding Site Group, in an all-cash deal for US$2.6 billion from Nordic Capital. In April 2021, Thermo Fisher Scientific announced the acquisition of PPD, Inc., a contract research organization, for a total cash purchase price of $17.4 billion-plus the assumption of approximately $3.5 billion of net debt. On August 13, the company announced that its offer to acquire all of the ordinary share had lapsed, and it terminated the acquisition agreement. In August, the company acquired Patheon, a contract development and manufacturing organization serving the pharmaceutical and biotechnology sectors, for approximately $7.2 billion. In March, the company announced it would acquire Core Informatics, provider of cloud-based platforms supporting scientific data management. On May 27, 2016, the company announced it would acquire FEI Company for $4.2 billion, a manufacturer of electron microscopes. In February 2015, the company announced it would acquire Advanced Scientifics for $300 million in a cash-deal. In May 2011, Thermo Fisher Scientific Inc. bought Phadia to expand into the testing of allergies and autoimmune diseases for €2.47 billion ($3.5 billion) in cash.

It made broad patents covering Enhanced GFP (EGFP), GFP-based biosensors and any genetically encoded protein fusion to a luminophore, with subsequent monitoring of the protein's translocation within a cell as the primary readout for drug discovery assays. In 1990, Thermo Fisher Scientific (then known as Thermo Instrument Systems) acquired mass spectrometer manufacturer Finnigan Instrument Corporation. In April 2007, Genevac was sold to Riverlake Partners LLC and the merger closed with FTC approval. However, the Federal Trade Commission ruled that this acquisition was anti-competitive regarding centrifugal evaporators, requiring Fisher to divest Genevac. It ranked 106th on the Fortune 500 list based on its 2025 annual revenue of $44.556 billion. Thermo Fisher Scientific has acquired other reagent, consumable, instrumentation, Adrians Casino and service providers, including Life Technologies Corporation (2013), Alfa Aesar (2015), Affymetrix (2016), FEI Company (2016), BD Advanced Bioprocessing (2018), and PPD (2021). Based in Waltham, Massachusetts, Thermo Fisher was formed through the merger of Thermo Electron and Fisher Scientific in 2006. The merger closed on November 9, 2006, and the merged company is now called Thermo Fisher Scientific.

This acquisition is anticipated to close in early 2017 and will contribute to the growth of Thermo's Analytical Instruments business group. In January 2016, the company announced it would acquire Affymetrix for $1.3 billion. The company also acquired GIBCO (Grand Island Biological Company) as part of the Life Technologies acquisition. Life Technologies was originally formed in 2008 through a $6.7B merger of Invitrogen, a cell therapy, and Applied Biosystems. In April 2013, after a competitive bidding with Hoffmann-La Roche, Thermo Fisher acquired Life Technologies Corporation for US$13.6 billion in a deal, adding further service lines related to advanced DNA sequencing and genetic testing. In December 2010, Thermo Fisher Scientific announced its acquisition of Dionex for $2.1 billion.

In March 2019, Thermo Fisher Scientific announced its entry into the gene therapy manufacturing market with a $1.7 billion cash acquisition for Brammer Bio. Thermo Scientific products address a range of needs from sample, material characterization, and chemical analysis to clinical diagnoses and biological-based therapeutics manufacturing. As the world’s leader in serving science, our professionals develop critical solutions—and build rewarding careers. Discover the resources that match your professional development interests, a culture that welcomes your ideas, and opportunities that only a global leader can provide. Over 50 million tons of her cells have been produced and used in over 60,000 scientific studies touching virtually every realm of medicine, including the development of polio vaccines, gene mapping, in-vitro fertilization, and multitudes more. In 2021, Thermo Fisher announced the construction of a cell therapy development, manufacturing and collaboration center in cooperation with University of California, San Francisco on the school's Mission Bay campus.

Grab Deals Before They're Gone

In June 2020, Thermo Fisher Scientific was reported to sell its equipment to security services in China for use in what was alleged as part of a genetic surveillance program. In February 2019, Thermo Fisher Scientific announced that it would stop selling its equipment in Xinjiang. In May 2023, Thermo Fisher partnered with Pfizer, with plans to work together on expanding testing capabilities for lung and breast cancer patients. The collaboration was designed to scale up the manufacturing of Moderna’s COVID-19 vaccine and other investigational mRNA products. Previously, he worked for clinical diagnostics provider Dade Behring Inc., serving as President–Americas. After the merger creating Thermo Fisher Scientific in 2006, he was named Executive Vice President and President of its Analytical Technologies business, and in 2008 he became the company’s Chief Operating Officer. In July 2025, Thermo Fisher added drug manufacturing capabilities in the United States through its purchase of a sterile fill-finish and packaging plant from Sanofi in Ridgefield, New Jersey.

In February 2025, Thermo Fisher announced the acquisition of Solventum’s purification and filtration business for $4.1 billion. In July 2023, the business announced it would acquire CorEvitas, LLC from Audax Private Equity for more than $900 million in cash. In January 2022, Thermo Fisher Scientific acquired PeproTech, a developer and manufacturer of recombinant proteins, for $1.85 billion. In November, the business announced it would acquire PharmaFluidics and its μPAC range of micro-chip-based chromatography products. In March 2020, Thermo Fisher Scientific agreed to purchase Qiagen, a molecular diagnostics company, for $10.1 billion. In November the company announced it would acquire MTI-GlobalStem, a previously privately held company that develops reagents for cell transfection, neurobiology and stem cell research.

Green Solutions

In the 1990s, Fisher, with partner Intertech Corporation of Atkinson, New Hampshire, set up a pharmaceutical testing and certification lab in Moscow, Russia, to serve with the Russian Federation's Ministry of Health and Medical Industry needs. The public entity was called Fisher Scientific International Inc., and based in Hampton, New Hampshire. Fisher was acquired by Morristown, New Jersey–based Allied Corporation in 1981 for $330 million. In 1968, it purchased Massachusetts-based Jarrell-Ash Company, a producer of optical instrumentation, particularly for emission and atomic absorption spectroscopy. It acquired Pfeiffer Glass, Inc. in 1966, a manufacturer of high accuracy volumetric pipettes. In 1959 the company opened an instrument and supplies facility in Indiana, Pennsylvania. In 1957, the company purchased the New York–based medical apparatus supply company E. In 1955, Fisher established a chemical manufacturing facility in Fair Lawn, New Jersey.

The merger was complete in November 2006, and technology transfer to a US site was completed during 2007 and 2008. It focused on providing laboratory equipment, chemicals, supplies and services used in healthcare, scientific research, safety, and education. It acquired Chicago-based Stansi Scientific Company in 1967, expanding into educational science supplies. As part of our global team, what you do contribues directly to our Mission, to enable our customers to make the world healthier, cleaner and safer. The images were claimed to validate the effectiveness of antibody products which have uses including Western blots. In 2013, Opengate Capital Group LLC filed suit against Thermo Fisher Scientific for selling it a manufacturing plant controlled by the Gulf Cartel. In June 2021, The New York Times reported that, despite bans, Thermo Fisher Scientific equipment continued to be sold to police in Xinjiang.

In October 2022, the company agreed to buy British diagnostics firm, The Binding Site Group, in an all-cash deal for US$2.6 billion from Nordic Capital. In April 2021, Thermo Fisher Scientific announced the acquisition of PPD, Inc., a contract research organization, for a total cash purchase price of $17.4 billion-plus the assumption of approximately $3.5 billion of net debt. On August 13, the company announced that its offer to acquire all of the ordinary share had lapsed, and it terminated the acquisition agreement. In August, the company acquired Patheon, a contract development and manufacturing organization serving the pharmaceutical and biotechnology sectors, for approximately $7.2 billion. In March, the company announced it would acquire Core Informatics, provider of cloud-based platforms supporting scientific data management. On May 27, 2016, the company announced it would acquire FEI Company for $4.2 billion, a manufacturer of electron microscopes. In February 2015, the company announced it would acquire Advanced Scientifics for $300 million in a cash-deal. In May 2011, Thermo Fisher Scientific Inc. bought Phadia to expand into the testing of allergies and autoimmune diseases for €2.47 billion ($3.5 billion) in cash.

It made broad patents covering Enhanced GFP (EGFP), GFP-based biosensors and any genetically encoded protein fusion to a luminophore, with subsequent monitoring of the protein's translocation within a cell as the primary readout for drug discovery assays. In 1990, Thermo Fisher Scientific (then known as Thermo Instrument Systems) acquired mass spectrometer manufacturer Finnigan Instrument Corporation. In April 2007, Genevac was sold to Riverlake Partners LLC and the merger closed with FTC approval. However, the Federal Trade Commission ruled that this acquisition was anti-competitive regarding centrifugal evaporators, requiring Fisher to divest Genevac. It ranked 106th on the Fortune 500 list based on its 2025 annual revenue of $44.556 billion. Thermo Fisher Scientific has acquired other reagent, consumable, instrumentation, Adrians Casino and service providers, including Life Technologies Corporation (2013), Alfa Aesar (2015), Affymetrix (2016), FEI Company (2016), BD Advanced Bioprocessing (2018), and PPD (2021). Based in Waltham, Massachusetts, Thermo Fisher was formed through the merger of Thermo Electron and Fisher Scientific in 2006. The merger closed on November 9, 2006, and the merged company is now called Thermo Fisher Scientific.

This acquisition is anticipated to close in early 2017 and will contribute to the growth of Thermo's Analytical Instruments business group. In January 2016, the company announced it would acquire Affymetrix for $1.3 billion. The company also acquired GIBCO (Grand Island Biological Company) as part of the Life Technologies acquisition. Life Technologies was originally formed in 2008 through a $6.7B merger of Invitrogen, a cell therapy, and Applied Biosystems. In April 2013, after a competitive bidding with Hoffmann-La Roche, Thermo Fisher acquired Life Technologies Corporation for US$13.6 billion in a deal, adding further service lines related to advanced DNA sequencing and genetic testing. In December 2010, Thermo Fisher Scientific announced its acquisition of Dionex for $2.1 billion.

In March 2019, Thermo Fisher Scientific announced its entry into the gene therapy manufacturing market with a $1.7 billion cash acquisition for Brammer Bio. Thermo Scientific products address a range of needs from sample, material characterization, and chemical analysis to clinical diagnoses and biological-based therapeutics manufacturing. As the world’s leader in serving science, our professionals develop critical solutions—and build rewarding careers. Discover the resources that match your professional development interests, a culture that welcomes your ideas, and opportunities that only a global leader can provide. Over 50 million tons of her cells have been produced and used in over 60,000 scientific studies touching virtually every realm of medicine, including the development of polio vaccines, gene mapping, in-vitro fertilization, and multitudes more. In 2021, Thermo Fisher announced the construction of a cell therapy development, manufacturing and collaboration center in cooperation with University of California, San Francisco on the school's Mission Bay campus.

Grab Deals Before They're Gone

In June 2020, Thermo Fisher Scientific was reported to sell its equipment to security services in China for use in what was alleged as part of a genetic surveillance program. In February 2019, Thermo Fisher Scientific announced that it would stop selling its equipment in Xinjiang. In May 2023, Thermo Fisher partnered with Pfizer, with plans to work together on expanding testing capabilities for lung and breast cancer patients. The collaboration was designed to scale up the manufacturing of Moderna’s COVID-19 vaccine and other investigational mRNA products. Previously, he worked for clinical diagnostics provider Dade Behring Inc., serving as President–Americas. After the merger creating Thermo Fisher Scientific in 2006, he was named Executive Vice President and President of its Analytical Technologies business, and in 2008 he became the company’s Chief Operating Officer. In July 2025, Thermo Fisher added drug manufacturing capabilities in the United States through its purchase of a sterile fill-finish and packaging plant from Sanofi in Ridgefield, New Jersey.

In February 2025, Thermo Fisher announced the acquisition of Solventum’s purification and filtration business for $4.1 billion. In July 2023, the business announced it would acquire CorEvitas, LLC from Audax Private Equity for more than $900 million in cash. In January 2022, Thermo Fisher Scientific acquired PeproTech, a developer and manufacturer of recombinant proteins, for $1.85 billion. In November, the business announced it would acquire PharmaFluidics and its μPAC range of micro-chip-based chromatography products. In March 2020, Thermo Fisher Scientific agreed to purchase Qiagen, a molecular diagnostics company, for $10.1 billion. In November the company announced it would acquire MTI-GlobalStem, a previously privately held company that develops reagents for cell transfection, neurobiology and stem cell research.

Green Solutions

In the 1990s, Fisher, with partner Intertech Corporation of Atkinson, New Hampshire, set up a pharmaceutical testing and certification lab in Moscow, Russia, to serve with the Russian Federation's Ministry of Health and Medical Industry needs. The public entity was called Fisher Scientific International Inc., and based in Hampton, New Hampshire. Fisher was acquired by Morristown, New Jersey–based Allied Corporation in 1981 for $330 million. In 1968, it purchased Massachusetts-based Jarrell-Ash Company, a producer of optical instrumentation, particularly for emission and atomic absorption spectroscopy. It acquired Pfeiffer Glass, Inc. in 1966, a manufacturer of high accuracy volumetric pipettes. In 1959 the company opened an instrument and supplies facility in Indiana, Pennsylvania. In 1957, the company purchased the New York–based medical apparatus supply company E. In 1955, Fisher established a chemical manufacturing facility in Fair Lawn, New Jersey.

The merger was complete in November 2006, and technology transfer to a US site was completed during 2007 and 2008. It focused on providing laboratory equipment, chemicals, supplies and services used in healthcare, scientific research, safety, and education. It acquired Chicago-based Stansi Scientific Company in 1967, expanding into educational science supplies. As part of our global team, what you do contribues directly to our Mission, to enable our customers to make the world healthier, cleaner and safer. The images were claimed to validate the effectiveness of antibody products which have uses including Western blots. In 2013, Opengate Capital Group LLC filed suit against Thermo Fisher Scientific for selling it a manufacturing plant controlled by the Gulf Cartel. In June 2021, The New York Times reported that, despite bans, Thermo Fisher Scientific equipment continued to be sold to police in Xinjiang.

In October 2022, the company agreed to buy British diagnostics firm, The Binding Site Group, in an all-cash deal for US$2.6 billion from Nordic Capital. In April 2021, Thermo Fisher Scientific announced the acquisition of PPD, Inc., a contract research organization, for a total cash purchase price of $17.4 billion-plus the assumption of approximately $3.5 billion of net debt. On August 13, the company announced that its offer to acquire all of the ordinary share had lapsed, and it terminated the acquisition agreement. In August, the company acquired Patheon, a contract development and manufacturing organization serving the pharmaceutical and biotechnology sectors, for approximately $7.2 billion. In March, the company announced it would acquire Core Informatics, provider of cloud-based platforms supporting scientific data management. On May 27, 2016, the company announced it would acquire FEI Company for $4.2 billion, a manufacturer of electron microscopes. In February 2015, the company announced it would acquire Advanced Scientifics for $300 million in a cash-deal. In May 2011, Thermo Fisher Scientific Inc. bought Phadia to expand into the testing of allergies and autoimmune diseases for €2.47 billion ($3.5 billion) in cash.

It made broad patents covering Enhanced GFP (EGFP), GFP-based biosensors and any genetically encoded protein fusion to a luminophore, with subsequent monitoring of the protein's translocation within a cell as the primary readout for drug discovery assays. In 1990, Thermo Fisher Scientific (then known as Thermo Instrument Systems) acquired mass spectrometer manufacturer Finnigan Instrument Corporation. In April 2007, Genevac was sold to Riverlake Partners LLC and the merger closed with FTC approval. However, the Federal Trade Commission ruled that this acquisition was anti-competitive regarding centrifugal evaporators, requiring Fisher to divest Genevac. It ranked 106th on the Fortune 500 list based on its 2025 annual revenue of $44.556 billion. Thermo Fisher Scientific has acquired other reagent, consumable, instrumentation, Adrians Casino and service providers, including Life Technologies Corporation (2013), Alfa Aesar (2015), Affymetrix (2016), FEI Company (2016), BD Advanced Bioprocessing (2018), and PPD (2021). Based in Waltham, Massachusetts, Thermo Fisher was formed through the merger of Thermo Electron and Fisher Scientific in 2006. The merger closed on November 9, 2006, and the merged company is now called Thermo Fisher Scientific.

This acquisition is anticipated to close in early 2017 and will contribute to the growth of Thermo's Analytical Instruments business group. In January 2016, the company announced it would acquire Affymetrix for $1.3 billion. The company also acquired GIBCO (Grand Island Biological Company) as part of the Life Technologies acquisition. Life Technologies was originally formed in 2008 through a $6.7B merger of Invitrogen, a cell therapy, and Applied Biosystems. In April 2013, after a competitive bidding with Hoffmann-La Roche, Thermo Fisher acquired Life Technologies Corporation for US$13.6 billion in a deal, adding further service lines related to advanced DNA sequencing and genetic testing. In December 2010, Thermo Fisher Scientific announced its acquisition of Dionex for $2.1 billion.

In March 2019, Thermo Fisher Scientific announced its entry into the gene therapy manufacturing market with a $1.7 billion cash acquisition for Brammer Bio. Thermo Scientific products address a range of needs from sample, material characterization, and chemical analysis to clinical diagnoses and biological-based therapeutics manufacturing. As the world’s leader in serving science, our professionals develop critical solutions—and build rewarding careers. Discover the resources that match your professional development interests, a culture that welcomes your ideas, and opportunities that only a global leader can provide. Over 50 million tons of her cells have been produced and used in over 60,000 scientific studies touching virtually every realm of medicine, including the development of polio vaccines, gene mapping, in-vitro fertilization, and multitudes more. In 2021, Thermo Fisher announced the construction of a cell therapy development, manufacturing and collaboration center in cooperation with University of California, San Francisco on the school's Mission Bay campus.

Grab Deals Before They're Gone

In June 2020, Thermo Fisher Scientific was reported to sell its equipment to security services in China for use in what was alleged as part of a genetic surveillance program. In February 2019, Thermo Fisher Scientific announced that it would stop selling its equipment in Xinjiang. In May 2023, Thermo Fisher partnered with Pfizer, with plans to work together on expanding testing capabilities for lung and breast cancer patients. The collaboration was designed to scale up the manufacturing of Moderna’s COVID-19 vaccine and other investigational mRNA products. Previously, he worked for clinical diagnostics provider Dade Behring Inc., serving as President–Americas. After the merger creating Thermo Fisher Scientific in 2006, he was named Executive Vice President and President of its Analytical Technologies business, and in 2008 he became the company’s Chief Operating Officer. In July 2025, Thermo Fisher added drug manufacturing capabilities in the United States through its purchase of a sterile fill-finish and packaging plant from Sanofi in Ridgefield, New Jersey.

In February 2025, Thermo Fisher announced the acquisition of Solventum’s purification and filtration business for $4.1 billion. In July 2023, the business announced it would acquire CorEvitas, LLC from Audax Private Equity for more than $900 million in cash. In January 2022, Thermo Fisher Scientific acquired PeproTech, a developer and manufacturer of recombinant proteins, for $1.85 billion. In November, the business announced it would acquire PharmaFluidics and its μPAC range of micro-chip-based chromatography products. In March 2020, Thermo Fisher Scientific agreed to purchase Qiagen, a molecular diagnostics company, for $10.1 billion. In November the company announced it would acquire MTI-GlobalStem, a previously privately held company that develops reagents for cell transfection, neurobiology and stem cell research.

Green Solutions

In the 1990s, Fisher, with partner Intertech Corporation of Atkinson, New Hampshire, set up a pharmaceutical testing and certification lab in Moscow, Russia, to serve with the Russian Federation's Ministry of Health and Medical Industry needs. The public entity was called Fisher Scientific International Inc., and based in Hampton, New Hampshire. Fisher was acquired by Morristown, New Jersey–based Allied Corporation in 1981 for $330 million. In 1968, it purchased Massachusetts-based Jarrell-Ash Company, a producer of optical instrumentation, particularly for emission and atomic absorption spectroscopy. It acquired Pfeiffer Glass, Inc. in 1966, a manufacturer of high accuracy volumetric pipettes. In 1959 the company opened an instrument and supplies facility in Indiana, Pennsylvania. In 1957, the company purchased the New York–based medical apparatus supply company E. In 1955, Fisher established a chemical manufacturing facility in Fair Lawn, New Jersey.

The merger was complete in November 2006, and technology transfer to a US site was completed during 2007 and 2008. It focused on providing laboratory equipment, chemicals, supplies and services used in healthcare, scientific research, safety, and education. It acquired Chicago-based Stansi Scientific Company in 1967, expanding into educational science supplies. As part of our global team, what you do contribues directly to our Mission, to enable our customers to make the world healthier, cleaner and safer. The images were claimed to validate the effectiveness of antibody products which have uses including Western blots. In 2013, Opengate Capital Group LLC filed suit against Thermo Fisher Scientific for selling it a manufacturing plant controlled by the Gulf Cartel. In June 2021, The New York Times reported that, despite bans, Thermo Fisher Scientific equipment continued to be sold to police in Xinjiang.

In October 2022, the company agreed to buy British diagnostics firm, The Binding Site Group, in an all-cash deal for US$2.6 billion from Nordic Capital. In April 2021, Thermo Fisher Scientific announced the acquisition of PPD, Inc., a contract research organization, for a total cash purchase price of $17.4 billion-plus the assumption of approximately $3.5 billion of net debt. On August 13, the company announced that its offer to acquire all of the ordinary share had lapsed, and it terminated the acquisition agreement. In August, the company acquired Patheon, a contract development and manufacturing organization serving the pharmaceutical and biotechnology sectors, for approximately $7.2 billion. In March, the company announced it would acquire Core Informatics, provider of cloud-based platforms supporting scientific data management. On May 27, 2016, the company announced it would acquire FEI Company for $4.2 billion, a manufacturer of electron microscopes. In February 2015, the company announced it would acquire Advanced Scientifics for $300 million in a cash-deal. In May 2011, Thermo Fisher Scientific Inc. bought Phadia to expand into the testing of allergies and autoimmune diseases for €2.47 billion ($3.5 billion) in cash.

It made broad patents covering Enhanced GFP (EGFP), GFP-based biosensors and any genetically encoded protein fusion to a luminophore, with subsequent monitoring of the protein's translocation within a cell as the primary readout for drug discovery assays. In 1990, Thermo Fisher Scientific (then known as Thermo Instrument Systems) acquired mass spectrometer manufacturer Finnigan Instrument Corporation. In April 2007, Genevac was sold to Riverlake Partners LLC and the merger closed with FTC approval. However, the Federal Trade Commission ruled that this acquisition was anti-competitive regarding centrifugal evaporators, requiring Fisher to divest Genevac. It ranked 106th on the Fortune 500 list based on its 2025 annual revenue of $44.556 billion. Thermo Fisher Scientific has acquired other reagent, consumable, instrumentation, Adrians Casino and service providers, including Life Technologies Corporation (2013), Alfa Aesar (2015), Affymetrix (2016), FEI Company (2016), BD Advanced Bioprocessing (2018), and PPD (2021). Based in Waltham, Massachusetts, Thermo Fisher was formed through the merger of Thermo Electron and Fisher Scientific in 2006. The merger closed on November 9, 2006, and the merged company is now called Thermo Fisher Scientific.

This acquisition is anticipated to close in early 2017 and will contribute to the growth of Thermo's Analytical Instruments business group. In January 2016, the company announced it would acquire Affymetrix for $1.3 billion. The company also acquired GIBCO (Grand Island Biological Company) as part of the Life Technologies acquisition. Life Technologies was originally formed in 2008 through a $6.7B merger of Invitrogen, a cell therapy, and Applied Biosystems. In April 2013, after a competitive bidding with Hoffmann-La Roche, Thermo Fisher acquired Life Technologies Corporation for US$13.6 billion in a deal, adding further service lines related to advanced DNA sequencing and genetic testing. In December 2010, Thermo Fisher Scientific announced its acquisition of Dionex for $2.1 billion.

In March 2019, Thermo Fisher Scientific announced its entry into the gene therapy manufacturing market with a $1.7 billion cash acquisition for Brammer Bio. Thermo Scientific products address a range of needs from sample, material characterization, and chemical analysis to clinical diagnoses and biological-based therapeutics manufacturing. As the world’s leader in serving science, our professionals develop critical solutions—and build rewarding careers. Discover the resources that match your professional development interests, a culture that welcomes your ideas, and opportunities that only a global leader can provide. Over 50 million tons of her cells have been produced and used in over 60,000 scientific studies touching virtually every realm of medicine, including the development of polio vaccines, gene mapping, in-vitro fertilization, and multitudes more. In 2021, Thermo Fisher announced the construction of a cell therapy development, manufacturing and collaboration center in cooperation with University of California, San Francisco on the school's Mission Bay campus.

Grab Deals Before They're Gone

In June 2020, Thermo Fisher Scientific was reported to sell its equipment to security services in China for use in what was alleged as part of a genetic surveillance program. In February 2019, Thermo Fisher Scientific announced that it would stop selling its equipment in Xinjiang. In May 2023, Thermo Fisher partnered with Pfizer, with plans to work together on expanding testing capabilities for lung and breast cancer patients. The collaboration was designed to scale up the manufacturing of Moderna’s COVID-19 vaccine and other investigational mRNA products. Previously, he worked for clinical diagnostics provider Dade Behring Inc., serving as President–Americas. After the merger creating Thermo Fisher Scientific in 2006, he was named Executive Vice President and President of its Analytical Technologies business, and in 2008 he became the company’s Chief Operating Officer. In July 2025, Thermo Fisher added drug manufacturing capabilities in the United States through its purchase of a sterile fill-finish and packaging plant from Sanofi in Ridgefield, New Jersey.

In February 2025, Thermo Fisher announced the acquisition of Solventum’s purification and filtration business for $4.1 billion. In July 2023, the business announced it would acquire CorEvitas, LLC from Audax Private Equity for more than $900 million in cash. In January 2022, Thermo Fisher Scientific acquired PeproTech, a developer and manufacturer of recombinant proteins, for $1.85 billion. In November, the business announced it would acquire PharmaFluidics and its μPAC range of micro-chip-based chromatography products. In March 2020, Thermo Fisher Scientific agreed to purchase Qiagen, a molecular diagnostics company, for $10.1 billion. In November the company announced it would acquire MTI-GlobalStem, a previously privately held company that develops reagents for cell transfection, neurobiology and stem cell research.

Green Solutions

In the 1990s, Fisher, with partner Intertech Corporation of Atkinson, New Hampshire, set up a pharmaceutical testing and certification lab in Moscow, Russia, to serve with the Russian Federation's Ministry of Health and Medical Industry needs. The public entity was called Fisher Scientific International Inc., and based in Hampton, New Hampshire. Fisher was acquired by Morristown, New Jersey–based Allied Corporation in 1981 for $330 million. In 1968, it purchased Massachusetts-based Jarrell-Ash Company, a producer of optical instrumentation, particularly for emission and atomic absorption spectroscopy. It acquired Pfeiffer Glass, Inc. in 1966, a manufacturer of high accuracy volumetric pipettes. In 1959 the company opened an instrument and supplies facility in Indiana, Pennsylvania. In 1957, the company purchased the New York–based medical apparatus supply company E. In 1955, Fisher established a chemical manufacturing facility in Fair Lawn, New Jersey.

The merger was complete in November 2006, and technology transfer to a US site was completed during 2007 and 2008. It focused on providing laboratory equipment, chemicals, supplies and services used in healthcare, scientific research, safety, and education. It acquired Chicago-based Stansi Scientific Company in 1967, expanding into educational science supplies. As part of our global team, what you do contribues directly to our Mission, to enable our customers to make the world healthier, cleaner and safer. The images were claimed to validate the effectiveness of antibody products which have uses including Western blots. In 2013, Opengate Capital Group LLC filed suit against Thermo Fisher Scientific for selling it a manufacturing plant controlled by the Gulf Cartel. In June 2021, The New York Times reported that, despite bans, Thermo Fisher Scientific equipment continued to be sold to police in Xinjiang.

In October 2022, the company agreed to buy British diagnostics firm, The Binding Site Group, in an all-cash deal for US$2.6 billion from Nordic Capital. In April 2021, Thermo Fisher Scientific announced the acquisition of PPD, Inc., a contract research organization, for a total cash purchase price of $17.4 billion-plus the assumption of approximately $3.5 billion of net debt. On August 13, the company announced that its offer to acquire all of the ordinary share had lapsed, and it terminated the acquisition agreement. In August, the company acquired Patheon, a contract development and manufacturing organization serving the pharmaceutical and biotechnology sectors, for approximately $7.2 billion. In March, the company announced it would acquire Core Informatics, provider of cloud-based platforms supporting scientific data management. On May 27, 2016, the company announced it would acquire FEI Company for $4.2 billion, a manufacturer of electron microscopes. In February 2015, the company announced it would acquire Advanced Scientifics for $300 million in a cash-deal. In May 2011, Thermo Fisher Scientific Inc. bought Phadia to expand into the testing of allergies and autoimmune diseases for €2.47 billion ($3.5 billion) in cash.

It made broad patents covering Enhanced GFP (EGFP), GFP-based biosensors and any genetically encoded protein fusion to a luminophore, with subsequent monitoring of the protein's translocation within a cell as the primary readout for drug discovery assays. In 1990, Thermo Fisher Scientific (then known as Thermo Instrument Systems) acquired mass spectrometer manufacturer Finnigan Instrument Corporation. In April 2007, Genevac was sold to Riverlake Partners LLC and the merger closed with FTC approval. However, the Federal Trade Commission ruled that this acquisition was anti-competitive regarding centrifugal evaporators, requiring Fisher to divest Genevac. It ranked 106th on the Fortune 500 list based on its 2025 annual revenue of $44.556 billion. Thermo Fisher Scientific has acquired other reagent, consumable, instrumentation, Adrians Casino and service providers, including Life Technologies Corporation (2013), Alfa Aesar (2015), Affymetrix (2016), FEI Company (2016), BD Advanced Bioprocessing (2018), and PPD (2021). Based in Waltham, Massachusetts, Thermo Fisher was formed through the merger of Thermo Electron and Fisher Scientific in 2006. The merger closed on November 9, 2006, and the merged company is now called Thermo Fisher Scientific.

This acquisition is anticipated to close in early 2017 and will contribute to the growth of Thermo's Analytical Instruments business group. In January 2016, the company announced it would acquire Affymetrix for $1.3 billion. The company also acquired GIBCO (Grand Island Biological Company) as part of the Life Technologies acquisition. Life Technologies was originally formed in 2008 through a $6.7B merger of Invitrogen, a cell therapy, and Applied Biosystems. In April 2013, after a competitive bidding with Hoffmann-La Roche, Thermo Fisher acquired Life Technologies Corporation for US$13.6 billion in a deal, adding further service lines related to advanced DNA sequencing and genetic testing. In December 2010, Thermo Fisher Scientific announced its acquisition of Dionex for $2.1 billion.

In March 2019, Thermo Fisher Scientific announced its entry into the gene therapy manufacturing market with a $1.7 billion cash acquisition for Brammer Bio. Thermo Scientific products address a range of needs from sample, material characterization, and chemical analysis to clinical diagnoses and biological-based therapeutics manufacturing. As the world’s leader in serving science, our professionals develop critical solutions—and build rewarding careers. Discover the resources that match your professional development interests, a culture that welcomes your ideas, and opportunities that only a global leader can provide. Over 50 million tons of her cells have been produced and used in over 60,000 scientific studies touching virtually every realm of medicine, including the development of polio vaccines, gene mapping, in-vitro fertilization, and multitudes more. In 2021, Thermo Fisher announced the construction of a cell therapy development, manufacturing and collaboration center in cooperation with University of California, San Francisco on the school's Mission Bay campus.

Grab Deals Before They're Gone

In June 2020, Thermo Fisher Scientific was reported to sell its equipment to security services in China for use in what was alleged as part of a genetic surveillance program. In February 2019, Thermo Fisher Scientific announced that it would stop selling its equipment in Xinjiang. In May 2023, Thermo Fisher partnered with Pfizer, with plans to work together on expanding testing capabilities for lung and breast cancer patients. The collaboration was designed to scale up the manufacturing of Moderna’s COVID-19 vaccine and other investigational mRNA products. Previously, he worked for clinical diagnostics provider Dade Behring Inc., serving as President–Americas. After the merger creating Thermo Fisher Scientific in 2006, he was named Executive Vice President and President of its Analytical Technologies business, and in 2008 he became the company’s Chief Operating Officer. In July 2025, Thermo Fisher added drug manufacturing capabilities in the United States through its purchase of a sterile fill-finish and packaging plant from Sanofi in Ridgefield, New Jersey.

In February 2025, Thermo Fisher announced the acquisition of Solventum’s purification and filtration business for $4.1 billion. In July 2023, the business announced it would acquire CorEvitas, LLC from Audax Private Equity for more than $900 million in cash. In January 2022, Thermo Fisher Scientific acquired PeproTech, a developer and manufacturer of recombinant proteins, for $1.85 billion. In November, the business announced it would acquire PharmaFluidics and its μPAC range of micro-chip-based chromatography products. In March 2020, Thermo Fisher Scientific agreed to purchase Qiagen, a molecular diagnostics company, for $10.1 billion. In November the company announced it would acquire MTI-GlobalStem, a previously privately held company that develops reagents for cell transfection, neurobiology and stem cell research.

Green Solutions

In the 1990s, Fisher, with partner Intertech Corporation of Atkinson, New Hampshire, set up a pharmaceutical testing and certification lab in Moscow, Russia, to serve with the Russian Federation's Ministry of Health and Medical Industry needs. The public entity was called Fisher Scientific International Inc., and based in Hampton, New Hampshire. Fisher was acquired by Morristown, New Jersey–based Allied Corporation in 1981 for $330 million. In 1968, it purchased Massachusetts-based Jarrell-Ash Company, a producer of optical instrumentation, particularly for emission and atomic absorption spectroscopy. It acquired Pfeiffer Glass, Inc. in 1966, a manufacturer of high accuracy volumetric pipettes. In 1959 the company opened an instrument and supplies facility in Indiana, Pennsylvania. In 1957, the company purchased the New York–based medical apparatus supply company E. In 1955, Fisher established a chemical manufacturing facility in Fair Lawn, New Jersey.

The merger was complete in November 2006, and technology transfer to a US site was completed during 2007 and 2008. It focused on providing laboratory equipment, chemicals, supplies and services used in healthcare, scientific research, safety, and education. It acquired Chicago-based Stansi Scientific Company in 1967, expanding into educational science supplies. As part of our global team, what you do contribues directly to our Mission, to enable our customers to make the world healthier, cleaner and safer. The images were claimed to validate the effectiveness of antibody products which have uses including Western blots. In 2013, Opengate Capital Group LLC filed suit against Thermo Fisher Scientific for selling it a manufacturing plant controlled by the Gulf Cartel. In June 2021, The New York Times reported that, despite bans, Thermo Fisher Scientific equipment continued to be sold to police in Xinjiang.

In October 2022, the company agreed to buy British diagnostics firm, The Binding Site Group, in an all-cash deal for US$2.6 billion from Nordic Capital. In April 2021, Thermo Fisher Scientific announced the acquisition of PPD, Inc., a contract research organization, for a total cash purchase price of $17.4 billion-plus the assumption of approximately $3.5 billion of net debt. On August 13, the company announced that its offer to acquire all of the ordinary share had lapsed, and it terminated the acquisition agreement. In August, the company acquired Patheon, a contract development and manufacturing organization serving the pharmaceutical and biotechnology sectors, for approximately $7.2 billion. In March, the company announced it would acquire Core Informatics, provider of cloud-based platforms supporting scientific data management. On May 27, 2016, the company announced it would acquire FEI Company for $4.2 billion, a manufacturer of electron microscopes. In February 2015, the company announced it would acquire Advanced Scientifics for $300 million in a cash-deal. In May 2011, Thermo Fisher Scientific Inc. bought Phadia to expand into the testing of allergies and autoimmune diseases for €2.47 billion ($3.5 billion) in cash.

It made broad patents covering Enhanced GFP (EGFP), GFP-based biosensors and any genetically encoded protein fusion to a luminophore, with subsequent monitoring of the protein's translocation within a cell as the primary readout for drug discovery assays. In 1990, Thermo Fisher Scientific (then known as Thermo Instrument Systems) acquired mass spectrometer manufacturer Finnigan Instrument Corporation. In April 2007, Genevac was sold to Riverlake Partners LLC and the merger closed with FTC approval. However, the Federal Trade Commission ruled that this acquisition was anti-competitive regarding centrifugal evaporators, requiring Fisher to divest Genevac. It ranked 106th on the Fortune 500 list based on its 2025 annual revenue of $44.556 billion. Thermo Fisher Scientific has acquired other reagent, consumable, instrumentation, Adrians Casino and service providers, including Life Technologies Corporation (2013), Alfa Aesar (2015), Affymetrix (2016), FEI Company (2016), BD Advanced Bioprocessing (2018), and PPD (2021). Based in Waltham, Massachusetts, Thermo Fisher was formed through the merger of Thermo Electron and Fisher Scientific in 2006. The merger closed on November 9, 2006, and the merged company is now called Thermo Fisher Scientific.

This acquisition is anticipated to close in early 2017 and will contribute to the growth of Thermo's Analytical Instruments business group. In January 2016, the company announced it would acquire Affymetrix for $1.3 billion. The company also acquired GIBCO (Grand Island Biological Company) as part of the Life Technologies acquisition. Life Technologies was originally formed in 2008 through a $6.7B merger of Invitrogen, a cell therapy, and Applied Biosystems. In April 2013, after a competitive bidding with Hoffmann-La Roche, Thermo Fisher acquired Life Technologies Corporation for US$13.6 billion in a deal, adding further service lines related to advanced DNA sequencing and genetic testing. In December 2010, Thermo Fisher Scientific announced its acquisition of Dionex for $2.1 billion.

In March 2019, Thermo Fisher Scientific announced its entry into the gene therapy manufacturing market with a $1.7 billion cash acquisition for Brammer Bio. Thermo Scientific products address a range of needs from sample, material characterization, and chemical analysis to clinical diagnoses and biological-based therapeutics manufacturing. As the world’s leader in serving science, our professionals develop critical solutions—and build rewarding careers. Discover the resources that match your professional development interests, a culture that welcomes your ideas, and opportunities that only a global leader can provide. Over 50 million tons of her cells have been produced and used in over 60,000 scientific studies touching virtually every realm of medicine, including the development of polio vaccines, gene mapping, in-vitro fertilization, and multitudes more. In 2021, Thermo Fisher announced the construction of a cell therapy development, manufacturing and collaboration center in cooperation with University of California, San Francisco on the school's Mission Bay campus.

Grab Deals Before They're Gone

In June 2020, Thermo Fisher Scientific was reported to sell its equipment to security services in China for use in what was alleged as part of a genetic surveillance program. In February 2019, Thermo Fisher Scientific announced that it would stop selling its equipment in Xinjiang. In May 2023, Thermo Fisher partnered with Pfizer, with plans to work together on expanding testing capabilities for lung and breast cancer patients. The collaboration was designed to scale up the manufacturing of Moderna’s COVID-19 vaccine and other investigational mRNA products. Previously, he worked for clinical diagnostics provider Dade Behring Inc., serving as President–Americas. After the merger creating Thermo Fisher Scientific in 2006, he was named Executive Vice President and President of its Analytical Technologies business, and in 2008 he became the company’s Chief Operating Officer. In July 2025, Thermo Fisher added drug manufacturing capabilities in the United States through its purchase of a sterile fill-finish and packaging plant from Sanofi in Ridgefield, New Jersey.

In February 2025, Thermo Fisher announced the acquisition of Solventum’s purification and filtration business for $4.1 billion. In July 2023, the business announced it would acquire CorEvitas, LLC from Audax Private Equity for more than $900 million in cash. In January 2022, Thermo Fisher Scientific acquired PeproTech, a developer and manufacturer of recombinant proteins, for $1.85 billion. In November, the business announced it would acquire PharmaFluidics and its μPAC range of micro-chip-based chromatography products. In March 2020, Thermo Fisher Scientific agreed to purchase Qiagen, a molecular diagnostics company, for $10.1 billion. In November the company announced it would acquire MTI-GlobalStem, a previously privately held company that develops reagents for cell transfection, neurobiology and stem cell research.

Green Solutions

In the 1990s, Fisher, with partner Intertech Corporation of Atkinson, New Hampshire, set up a pharmaceutical testing and certification lab in Moscow, Russia, to serve with the Russian Federation's Ministry of Health and Medical Industry needs. The public entity was called Fisher Scientific International Inc., and based in Hampton, New Hampshire. Fisher was acquired by Morristown, New Jersey–based Allied Corporation in 1981 for $330 million. In 1968, it purchased Massachusetts-based Jarrell-Ash Company, a producer of optical instrumentation, particularly for emission and atomic absorption spectroscopy. It acquired Pfeiffer Glass, Inc. in 1966, a manufacturer of high accuracy volumetric pipettes. In 1959 the company opened an instrument and supplies facility in Indiana, Pennsylvania. In 1957, the company purchased the New York–based medical apparatus supply company E. In 1955, Fisher established a chemical manufacturing facility in Fair Lawn, New Jersey.

The merger was complete in November 2006, and technology transfer to a US site was completed during 2007 and 2008. It focused on providing laboratory equipment, chemicals, supplies and services used in healthcare, scientific research, safety, and education. It acquired Chicago-based Stansi Scientific Company in 1967, expanding into educational science supplies. As part of our global team, what you do contribues directly to our Mission, to enable our customers to make the world healthier, cleaner and safer. The images were claimed to validate the effectiveness of antibody products which have uses including Western blots. In 2013, Opengate Capital Group LLC filed suit against Thermo Fisher Scientific for selling it a manufacturing plant controlled by the Gulf Cartel. In June 2021, The New York Times reported that, despite bans, Thermo Fisher Scientific equipment continued to be sold to police in Xinjiang.